Q1 2024 13F Holders as of 31 Mar 2024
-
Type / Class
-
Equity / Common stock, $0.01 par value per share
-
Shares outstanding
-
109,265,652
-
Total 13F shares
-
92,048,164
-
Share change
-
+4,173,178
-
Total reported value
-
$2,479,705,726
-
Put/Call ratio
-
46%
-
Price per share
-
$26.94
-
Number of holders
-
183
-
Value change
-
+$111,013,838
-
Number of buys
-
86
-
Number of sells
-
87
Institutional Holders of Rocket Pharmaceuticals, Inc. - Common stock, $0.01 par value per share (RCKT) as of Q1 2024
As of 31 Mar 2024,
Rocket Pharmaceuticals, Inc. - Common stock, $0.01 par value per share (RCKT) was held by
183 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
92,048,164 shares.
The largest 10 holders included
RTW INVESTMENTS, LP, WELLINGTON MANAGEMENT GROUP LLP, BlackRock Inc., VANGUARD GROUP INC, STATE STREET CORP, WESTFIELD CAPITAL MANAGEMENT CO LP, MAVERICK CAPITAL LTD, PRICE T ROWE ASSOCIATES INC /MD/, JANUS HENDERSON GROUP PLC, and CITADEL ADVISORS LLC.
This page lists
183
institutional shareholders reporting positions in this security
for the Q1 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.